医学临床研究
  2025年4月7日 星期一           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2023, Vol. 40 Issue (5): 735-737    DOI: 10.3969/j.issn.1671-7171.2023.05.027
  论著 本期目录 | 过刊浏览 | 高级检索 |
神经元表达发育下调基因9诊断胰腺癌及其对患者预后的预测价值
徐玉, 何海涛*, 魏志力, 查育锋, 何晓虎, 周彬, 周泽, 刘文涛
陕西中医药大学第二附属医院普外肝胆一科,陕西 西咸新区 712000
Value of NEDD9 for Diagnosis and Prediction of Prognosis in Pancreatic Cancer
XU Yu, HE Hai-tao, WEI Zhi-li, et al
The Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Xixian New District Shaanxi 712000
全文: PDF (1103 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨神经元表达发育下调基因9(NEDD9)诊断胰腺癌及其预测患者预后的价值。【方法】80例在本院首次就诊并经手术中快速病理活检证实的胰腺癌患者,收集患者胰腺癌组织及癌旁正常组织,采用免疫组化及qPCR技术检测各组织NEDD9的表达情况,分析NEDD9与胰腺癌患者临床特征的关系,探讨NDEE9对胰腺癌患者临床预后的影响。【结果】胰腺癌组织中的NEDD9高表达率为71.25%,显著高于癌旁组织的51.25%(P<0.05),其NEDD9 mRNA水平(0.92±0.17)也显著高于癌旁正常组织(0.33±0.09),差异有统计学意义P<0.05);低表达NEDD9患者的临床分期(Ⅰ~Ⅱ期)、分化程度(高分化)显著优于高表达NEDD9患者,同时淋巴结转移率显著低于高表达患者(均P<0.05);随访结果显示,发生预后不良的患者NEDD9表达水平(1.21±0.31)显著高于预后良好组(0.73±0.25)(P<0.05);二元Logistic回归分析显示,高表达NEDD9是胰腺癌患者预后不佳的独立危险因素,其优势比为2.18(1.16~4.01)。【结论】NEDD9在胰腺癌组织中呈显著高表达,且与患者临床分期及病例分级有相关性,NEDD9高表达是胰腺癌患者预后不佳的独立危险因素。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 胰腺肿瘤/遗传学胰腺肿瘤/诊断基因预后    
Abstract:【Objective】 To investigate the value of neuronal expression developmentally downregulated gene 9(NEDD9) for diagnosis and prediction of prognosis in pancreatic cancer. 【Methods】A total of 80 patients with pancreatic cancer,who were treated for the first time in our hospital and confirmed by rapid pathological biopsy,were enrolled in the study. The pancreatic cancer tissues and normal tissues adjacent to the cancer were collected. The expression of NEDD9 in pancreatic cancer tissues and normal tissues was detected by both immunohistochemistry and qPCR. The relationship between NEDD9 and clinical features of pancreatic cancer was analyzed. And the effect of NDEE9 on clinical prognosis of patients with pancreatic cancer was discussed. 【Results】Compared to normal tissues,the expression rate of NEDD9 in pancreatic cancer tissues was significantly higher (71.25% vs 51.25%,P<0.05); And the level of NEDD9 mRNA was also significantly higher than that of normal tissue (0.92±0.17) vs (0.33±0.09),P<0.05). The clinical stage (stage Ⅰ-Ⅱ) and degree of differentiation (high differentiation) in patients with low expression of NEDD9 were significantly better than those who had higher expression level of NEDD9.Follow-up results showed that the expression level of NEDD9 in patients with poor prognosis (1.21±0.31) was significantly higher than that in the group with good prognosis (0.73±0.25) (P<0.05).Binary logistic regression analysis found that high expression of NEDD9 was an independent risk factor for negative prognosis of pancreatic cancer,and its odds ratio was 2.18 (1.16-4.01).【Conclusion】 NEDD9 was highly expressed in pancreatic cancer tissues and it was associated with clinical stage and pancreatic cancer grading. The high expression of NEDD9 was an independent risk factor for negative prognosis in patients with pancreatic cancer.
Key wordsPancreatic Neoplasms/GE    Pancreatic Neoplasms/DI    Genes    Prognosis
收稿日期: 2022-05-10     
中图分类号:  R735.9  
通讯作者: *E-mail:jingyanghaitao@163.com   
引用本文:   
徐玉, 何海涛, 魏志力, 查育锋, 何晓虎, 周彬, 周泽, 刘文涛. 神经元表达发育下调基因9诊断胰腺癌及其对患者预后的预测价值[J]. 医学临床研究, 2023, 40(5): 735-737.
XU Yu, HE Hai-tao, WEI Zhi-li, et al. Value of NEDD9 for Diagnosis and Prediction of Prognosis in Pancreatic Cancer. JOURNAL OF CLINICAL RESEARCH, 2023, 40(5): 735-737.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2023.05.027     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2023/V40/I5/735
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn